PCRX logo

Pacira BioSciences (PCRX) Interest Expense

Annual Interest Expense

$17.31 M
-$18.27 M-51.34%

December 31, 2023

Summary

Performance

1-Year Change

-51.34%

3-Year Change

-26.39%

5-Year Change

-14.79%

15-Year Change

+3.86%

PCRX Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.78%
PCRX annual interest expense is higher than 74.78% of companies in Healthcare sector

High & Low

All-time High

$35.58 M
PCRX annual interest expense is currently -51.34% below its historical high of $35.58 million

3-Year Low

$17.31 M
PCRX annual interest expense is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PCRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
PCRX next annual earnings announcement is scheduled for Feb 28, 2025

OtherPCRXexpensesmetrics:

Annual Total Expenses

$587.65 M
PCRX annual total expenses is $587.65 million

Annual Operating Expenses

$402.99 M
PCRX annual total operating expenses is $402.99 million

Annual Cost Of Goods Sold

$184.67 M
PCRX annual cost of goods sold is $184.67 million

Annual Income Tax

$19.75 M
PCRX annual income tax is $19.75 million

Quarterly Interest Expense

$3.85 M
+$728.00 K+23.33%

September 30, 2024

Summary

Performance

3-Month Change

+23.33%

1-Year Change

+38.4%

3-Year Change

-57.55%

5-Year Change

-57.55%

PCRX Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.61%
PCRX quarterly interest expense is higher than 68.61% of companies in Healthcare sector

High & Low

All-time High

$9.64 M
PCRX quarterly interest expense is currently -60.09% below its historical high of $9.64 million

3-Year Low

$2.63 M
PCRX quarterly interest expense is currently +46.07% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PCRX next earnings announcement is scheduled for Feb 28, 2025

OtherPCRXexpensesmetrics:

Quarterly Total Expenses

$146.62 M
PCRX quarterly total expenses is $146.62 million

Quarterly Operating Expenses

$107.76 M
PCRX quarterly total operating expenses is $107.76 million

Quarterly Cost Of Goods Sold

$38.86 M
PCRX quarterly cost of goods sold is $38.86 million

Quarterly Income Tax

$4.61 M
PCRX quarterly income tax is $4.61 million

TTM Interest Expense

$12.31 M
+$1.07 M+9.50%

September 30, 2024

Summary

Performance

3-Month Change

+9.5%

1-Year Change

-49.15%

3-Year Change

-61.23%

5-Year Change

-61.23%

PCRX TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.81%
PCRX TTM interest expense is higher than 66.81% of companies in Healthcare sector

High & Low

All-time High

$35.62 M
PCRX TTM interest expense is currently -65.45% below its historical high of $35.62 million

3-Year Low

$11.24 M
PCRX TTM interest expense is currently +9.50% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PCRX next earnings announcement is scheduled for Feb 28, 2025

OtherPCRXexpensesmetrics:

Annual Total Expenses

$587.65 M
PCRX annual total expenses is $587.65 million

Annual Operating Expenses

$402.99 M
PCRX annual total operating expenses is $402.99 million

TTM Cost Of Goods Sold

$178.23 M
PCRX TTM cost of goods sold is $178.23 million

TTM Income Tax

$35.82 M
PCRX TTM income tax is $35.82 million

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

PCRX Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-51.3%+38.4%-49.1%
3 y3 years-26.4%-57.5%-61.2%
5 y5 years-14.8%-57.5%-61.2%

PCRX Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-51.3%at low-60.1%+46.1%-65.5%+9.5%
5 y5-year-51.3%at low-60.1%+46.1%-65.5%+9.5%
alltimeall time-51.3%+857.9%-60.1%+1022.2%-65.5%+2513.2%

Pacira BioSciences Interest Expense History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.85 M(+23.3%)
$12.31 M(+9.5%)
Jun 2024
-
$3.12 M(+18.4%)
$11.24 M(-0.5%)
Mar 2024
-
$2.63 M(-2.5%)
$11.29 M(-34.8%)
Dec 2023
$17.31 M(-51.3%)
$2.70 M(-2.8%)
$17.31 M(-28.5%)
Sep 2023
-
$2.78 M(-12.4%)
$24.20 M(-20.3%)
Jun 2023
-
$3.17 M(-63.3%)
$30.38 M(-13.6%)
Mar 2023
-
$8.65 M(-9.8%)
$35.16 M(-1.2%)
Dec 2022
$35.58 M(+22.7%)
$9.60 M(+7.2%)
$35.58 M(-0.1%)
Sep 2022
-
$8.95 M(+12.5%)
$35.62 M(+6.9%)
Jun 2022
-
$7.96 M(-12.2%)
$33.34 M(+5.0%)
Mar 2022
-
$9.07 M(-6.0%)
$31.74 M(+9.5%)
Dec 2021
$29.00 M(+23.3%)
$9.64 M(+44.7%)
$29.00 M(+12.5%)
Sep 2021
-
$6.67 M(+4.8%)
$25.77 M(+0.6%)
Jun 2021
-
$6.36 M(+0.7%)
$25.61 M(+5.6%)
Mar 2021
-
$6.32 M(-1.5%)
$24.25 M(+3.1%)
Dec 2020
$23.52 M(+7.3%)
$6.42 M(-1.3%)
$23.52 M(+3.8%)
Sep 2020
-
$6.50 M(+29.7%)
$22.66 M(+4.6%)
Jun 2020
-
$5.01 M(-10.2%)
$21.67 M(-2.0%)
Mar 2020
-
$5.58 M(+0.4%)
$22.11 M(+0.9%)
Dec 2019
$21.92 M(+7.9%)
$5.56 M(+0.9%)
$21.92 M(+1.0%)
Sep 2019
-
$5.51 M(+1.0%)
$21.70 M(+1.3%)
Jun 2019
-
$5.45 M(+1.1%)
$21.42 M(+2.2%)
Mar 2019
-
$5.39 M(+1.0%)
$20.95 M(+3.1%)
Dec 2018
$20.32 M(+21.9%)
$5.34 M(+2.1%)
$20.32 M(+3.2%)
Sep 2018
-
$5.23 M(+4.8%)
$19.68 M(+2.6%)
Jun 2018
-
$4.99 M(+5.0%)
$19.19 M(+0.8%)
Mar 2018
-
$4.75 M(+1.0%)
$19.03 M(+14.2%)
Dec 2017
$16.67 M(+158.4%)
$4.71 M(-0.5%)
$16.67 M(+22.0%)
Sep 2017
-
$4.73 M(-2.1%)
$13.66 M(+31.7%)
Jun 2017
-
$4.84 M(+102.6%)
$10.38 M(+45.7%)
Mar 2017
-
$2.39 M(+40.1%)
$7.12 M(+10.4%)
DateAnnualQuarterlyTTM
Dec 2016
$6.45 M(-9.3%)
$1.71 M(+17.7%)
$6.45 M(-0.4%)
Sep 2016
-
$1.45 M(-8.4%)
$6.47 M(-4.5%)
Jun 2016
-
$1.58 M(-7.9%)
$6.78 M(-3.0%)
Mar 2016
-
$1.72 M(-0.8%)
$6.98 M(-1.8%)
Dec 2015
$7.11 M(-7.2%)
$1.73 M(-1.3%)
$7.11 M(-2.4%)
Sep 2015
-
$1.75 M(-2.0%)
$7.28 M(-1.8%)
Jun 2015
-
$1.79 M(-2.9%)
$7.41 M(-1.8%)
Mar 2015
-
$1.84 M(-3.2%)
$7.55 M(-3.4%)
Dec 2014
$7.66 M(+15.0%)
$1.90 M(+1.0%)
$7.81 M(+7.8%)
Sep 2014
-
$1.88 M(-2.2%)
$7.25 M(-0.1%)
Jun 2014
-
$1.92 M(-8.7%)
$7.26 M(+0.1%)
Mar 2014
-
$2.11 M(+57.8%)
$7.25 M(+8.8%)
Dec 2013
$6.66 M(+268.6%)
$1.33 M(-29.4%)
$6.66 M(+17.5%)
Sep 2013
-
$1.89 M(-1.1%)
$5.67 M(+33.9%)
Jun 2013
-
$1.91 M(+26.0%)
$4.23 M(+50.5%)
Mar 2013
-
$1.52 M(+342.9%)
$2.81 M(+55.6%)
Dec 2012
$1.81 M(-62.2%)
$343.00 K(-24.8%)
$1.81 M(-17.0%)
Sep 2012
-
$456.00 K(-7.7%)
$2.18 M(-17.3%)
Jun 2012
-
$494.00 K(-3.9%)
$2.63 M(-6.5%)
Mar 2012
-
$514.00 K(-27.8%)
$2.81 M(-41.2%)
Dec 2011
$4.78 M(+20.7%)
$712.00 K(-21.8%)
$4.78 M(-12.3%)
Sep 2011
-
$910.00 K(+34.6%)
$5.45 M(-3.0%)
Jun 2011
-
$676.00 K(-72.8%)
$5.62 M(-3.6%)
Mar 2011
-
$2.48 M(+79.5%)
$5.83 M(+41.1%)
Dec 2010
$3.96 M(+9.9%)
$1.38 M(+28.3%)
$4.13 M(-23.0%)
Sep 2010
-
$1.08 M(+21.4%)
$5.36 M(+12.7%)
Jun 2010
-
$887.00 K(+13.1%)
$4.75 M(+22.9%)
Mar 2010
-
$784.00 K(-70.0%)
$3.87 M(+25.4%)
Dec 2009
$3.60 M(+3.2%)
$2.61 M(+454.8%)
$3.08 M(+554.8%)
Sep 2009
-
$471.00 K
$471.00 K
Dec 2008
$3.49 M
-
-

FAQ

  • What is Pacira BioSciences annual interest expense?
  • What is the all time high annual interest expense for Pacira BioSciences?
  • What is Pacira BioSciences annual interest expense year-on-year change?
  • What is Pacira BioSciences quarterly interest expense?
  • What is the all time high quarterly interest expense for Pacira BioSciences?
  • What is Pacira BioSciences quarterly interest expense year-on-year change?
  • What is Pacira BioSciences TTM interest expense?
  • What is the all time high TTM interest expense for Pacira BioSciences?
  • What is Pacira BioSciences TTM interest expense year-on-year change?

What is Pacira BioSciences annual interest expense?

The current annual interest expense of PCRX is $17.31 M

What is the all time high annual interest expense for Pacira BioSciences?

Pacira BioSciences all-time high annual interest expense is $35.58 M

What is Pacira BioSciences annual interest expense year-on-year change?

Over the past year, PCRX annual interest expense has changed by -$18.27 M (-51.34%)

What is Pacira BioSciences quarterly interest expense?

The current quarterly interest expense of PCRX is $3.85 M

What is the all time high quarterly interest expense for Pacira BioSciences?

Pacira BioSciences all-time high quarterly interest expense is $9.64 M

What is Pacira BioSciences quarterly interest expense year-on-year change?

Over the past year, PCRX quarterly interest expense has changed by +$1.07 M (+38.40%)

What is Pacira BioSciences TTM interest expense?

The current TTM interest expense of PCRX is $12.31 M

What is the all time high TTM interest expense for Pacira BioSciences?

Pacira BioSciences all-time high TTM interest expense is $35.62 M

What is Pacira BioSciences TTM interest expense year-on-year change?

Over the past year, PCRX TTM interest expense has changed by -$11.90 M (-49.15%)